Metraipolis › archive › dc_7296cf9949cc

Microbiota and Pancreatic Cancer: New Therapeutic Frontiers Between Engineered Microbes, Metabolites and Non-Bacterial Components — Europe PMC PMID:41300985

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41300985
DOI: 10.3390/cancers17223618
License (as archived): solo-consultazione
Archived: 2026-11-08T16:32:28.161Z
SHA-256 of the archived text: 63d503d91bf465ecb0bdbe99fd81d4b5e7f26a086049922906407b46479316d6
Stable URL of this page: https://metraipolis.com/documento/dc_7296cf9949cc

How to cite

Microbiota and Pancreatic Cancer: New Therapeutic Frontiers Between Engineered Microbes, Metabolites and Non-Bacterial Components — Europe PMC PMID:41300985 — Europe PMC (en), https://europepmc.org/article/MED/41300985 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7296cf9949cc (Metraipolis archive dc_7296cf9949cc, sha256 63d503d91bf465ecb0bdbe99fd81d4b5e7f26a086049922906407b46479316d6)

BibTeX

@misc{dc7296cf9949cc,
  title = {Microbiota and Pancreatic Cancer: New Therapeutic Frontiers Between Engineered Microbes, Metabolites and Non-Bacterial Components — Europe PMC PMID:41300985},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41300985},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7296cf9949cc; sha256 63d503d91bf465ecb0bdbe99fd81d4b5e7f26a086049922906407b46479316d6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41300985. Agents can read the archived copy with the MCP tool read_document.